This massive acquisition will create significant post-merger integration challenges, requiring consolidation of ERP, CRM, HRIS, and supply chain systems.
Filing excerpt
On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc. (Penumbra), a publicly traded medical technology company primarily focused on thrombectomy products for use in peripheral vascular procedures in the removal of blood clots and blockages.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Competitors named
sec-10qdigitalTransformationGet every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c1e990bd-20c7-4969-9d5b-facf96d96314 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "c1e990bd-20c7-4969-9d5b-facf96d96314",
"signal_type": "sec-10q",
"signal_subtype": "digitalTransformation",
"detected_at": "2026-05-05T08:48:22.684+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "This massive acquisition will create significant post-merger integration challenges, requiring consolidation of ERP, CRM, HRIS, and supply chain systems. This is a major opportunity for vendors specializing in large-scale system integration and business process re-engineering.",
"metrics": {
"timeframe": "next_year",
"dollar_context": "Purchase price for the acquisition of Penumbra, Inc.",
"dollar_millions": 14500
},
"summary": "Planning $14.5B acquisition of Penumbra, Inc., to close in H2 2026, funded by $11B in new debt.",
"excerpts": "On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc. (Penumbra), a publicly traded medical technology company primarily focused on thrombectomy products for use in peripheral vascular procedures in the removal of blood clots and blockages.",
"relevance": 1,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Multi-year tech investment",
"signal_category": "strategic",
"competitors_mentioned": [
"Penumbra, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/c1e990bd-20c7-4969-9d5b-facf96d96314 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.